T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Shutterstock
SSTK
$217M
| $234M | 0.05% |
3,402,382
+142,738
| +4% | +$8.67M |
|
402
Nordson
NDSN
$17.3B
| $233M | 0.05% |
2,970,620
-329,753
| -10% | -$25M |
|
|
BLUE
403
DELISTED
bluebird bio
BLUE
| $232M | 0.05% |
148,322
+31,214
| +27% | +$41.2M |
|
|
PSB
404
DELISTED
PS Business Parks, Inc.
PSB
| $231M | 0.05% |
2,777,085
+173,615
| +7% | +$14.4M |
|
|
PFPT
405
DELISTED
Proofpoint, Inc.
PFPT
| $230M | 0.05% |
3,887,230
-958,777
| -20% | -$51.6M |
|
|
FNFG
406
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $230M | 0.05% |
26,022,030
+986,942
| +4% | +$8.42M |
|
407
Southern Copper
SCCO
$158B
| $228M | 0.05% |
8,527,639
-551,593
| -6% | -$14.5M |
|
408
White Mountains Insurance
WTM
$5.11B
| $228M | 0.05% |
332,721
+3,950
| +1% | +$2.61M |
|
409
Cintas
CTAS
$80.3B
| $227M | 0.05% |
11,128,584
+62,840
| +0.6% | +$1.27M |
|
410
Louisiana-Pacific
LPX
$5.18B
| $225M | 0.05% |
13,647,644
+4,224,584
| +45% | +$69.6M |
|
|
THOR
411
DELISTED
THORATEC CORPORATION
THOR
| $225M | 0.05% |
5,363,179
-820,188
| -13% | -$31.3M |
|
412
Cognizant
CTSH
$26.7B
| $223M | 0.05% |
3,577,646
+511,201
| +17% | +$30.1M |
|
413
Kimco Realty
KIM
$16.4B
| $223M | 0.05% |
8,294,656
-44,430
| -0.5% | -$1.19M |
|
414
SBA Communications
SBAC
$19.8B
| $221M | 0.05% |
1,888,014
-63,448
| -3% | -$7.49M |
|
415
Douglas Emmett
DEI
$1.99B
| $219M | 0.05% |
7,353,740
+806,360
| +12% | +$23.4M |
|
416
TJX Companies
TJX
$170B
| $219M | 0.05% |
6,249,286
+2,670,872
| +75% | +$90.9M |
|
417
PPG Industries
PPG
$25.5B
| $218M | 0.05% |
1,937,488
+1,686
| +0.1% | +$193K |
|
|
GWR
418
DELISTED
Genesee & Wyoming Inc.
GWR
| $218M | 0.05% |
2,265,338
-263,370
| -10% | -$24.6M |
|
419
Western Alliance Bancorporation
WAL
$8.92B
| $218M | 0.05% |
7,368,267
-2,250
| -0% | -$62.7K |
|
420
BWX Technologies
BWXT
$15.6B
| $217M | 0.04% |
9,469,684
-8,353,190
| -47% | -$176M |
|
421
East-West Bancorp
EWBC
$18.6B
| $214M | 0.04% |
5,277,361
-2,266,085
| -30% | -$88.6M |
|
422
BP
BP
$110B
| $213M | 0.04% |
6,574,899
+723
| +0% | +$23.7K |
|
|
FLTX
423
DELISTED
Fleetmatics Group PLC
FLTX
| $213M | 0.04% |
4,742,943
-1,064,450
| -18% | -$42.1M |
|
424
Microchip Technology
MCHP
$42.2B
| $211M | 0.04% |
8,634,600
+138,652
| +2% | +$3.34M |
|
|
EA
425
DELISTED
Electronic Arts
EA
| $211M | 0.04% |
3,583,949
+409,347
| +13% | +$22.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.